WHAT CHANGED FOR LEANA WEN — The George Washington University public health professor, Washington Post columnist and former Baltimore health commissioner has become one of the most prominent voices advancing a controversial take: It is time to return to normal and has been for a while. It wasn't always like this. When the Biden administration announced vaccine requirements for U.S. employers, Wen argued they should have gone further. She's lamented rapid returns to schools and the coronavirus risks for children. Roughly 35,000 new cases a day are still being reported, though hospitalization rates remain flat. The youngest kids remain unvaccinated and are unlikely to see shots before June. New vaccination rates have stagnated. So, what changed? Public sentiment and her own risk calculus, Wen told Pulse. She and her husband wanted their two young children, one born during the pandemic, to experience life with peers and playdates. "That is where most Americans are and, frankly, where they have been throughout the pandemic, which is that they want to find the best way to navigate their lives." In other words, "public health depends on public trust," and the public is tired, Wen said. Wen insists she didn't pivot, pointing to an April 2021 column in which she urged vaccinated people to return to normal. Within a month of that column, the Delta variant hit, causing a hospitalization surge and the first of several waves of breakthrough cases. Wen maintains it wasn't her take that was wrong but the government's messaging — Biden officials should've never assumed the vaccine would stamp out all infections. Critics argue this isn't her call. People who are immunocompromised, particularly, say that increasingly relaxed public health guidance leaves their safety out of the equation — and they could still die from this virus. "It's true," Wen told Pulse. "I think it could both be true that the majority of individuals, if they are vaccinated and boosted, should be able to resume pre-pandemic normal, [and] we have to do a lot more when it comes to protecting the most vulnerable," including more accessible treatment. That stance — that most should move on even if others can't — has infuriated many doctors and public health experts, especially since some treatments aren't yet widely available. The simmering frustration boiled over this week when New York-based doctor and Health Justice director Oni Blackstock tweeted at Wen that her approach is "harmful and ableist" and beseeched her to consider her impact on public opinion. Blackstock later tweeted that Wen blocked her. Wen's 189,000-strong Twitter following, regular CNN appearances and previous reputation for divisiveness — she was abruptly ousted as Planned Parenthood head in 2019 — have made her a lightning rod on this issue even as administration officials endorse relaxed measures. Wen also has some direct lines into the White House as part of a group of health experts who have received private briefings on Covid policy throughout the pandemic. Twitter battles parallel anxiety in the Biden administration about how to message risk and responsibility in the pandemic's current phase when thousands are still dying but mask mandates have ended and social norms like conventions and concerts are back. Despite once supporting federal mandates, Wen now realizes they were never going to change some people's decision to mask or not. "We live in this very individualistic society where the incentive to do good for society may not be as strong as the incentive to have something personally," she told Pulse. "We should have said to people from the beginning: 'If you're vaccinated, you can take off your mask, you can go back to doing whatever you would like, understanding that there is still risk.' "That would have been the strongest incentive for vaccinations, and we lost them early on." THE FIRST LOBBYING NUMBERS OF THE YEAR ARE IN — K Street had until Thursday to submit lobbying filings for the first quarter of 2022, which runs from January through March — and the health sector set its year off with a bang, Megan reports. Seventy-five health care companies and associations spent $500,000 or more on lobbying in Q1 — and 44 of them increased their advocacy outlays by 10 percent or more from the same period in 2021, according to a POLITICO analysis of disclosures sent to the Senate. The top three health spenders remained the same — key industry groups for drugmakers, hospitals and doctors — but America's Health Insurance Plans, which represents insurers, spent $4.7 million on lobbying. That's a 20 percent boost over last year's first-quarter figure and the highest amount the group has ever spent on lobbying in any quarter. (A spokesperson didn't immediately respond to a request to comment on the figure.)
|
Comments
Post a Comment